» Articles » PMID: 22898630

Serum Nutritional Markers for Prediction of Pancreatic Exocrine Insufficiency in Chronic Pancreatitis

Overview
Journal Pancreatology
Date 2012 Aug 18
PMID 22898630
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Methods for evaluation of pancreatic exocrine insufficiency (PEI) are expensive, labor intensive, and not available at many institutions. The aim of this study was to investigate if PEI in chronic pancreatitis (CP) can by predicted by nutritional markers in blood.

Methods: A retrospective analysis of a prospectively collected database of CP patients was performed. Diagnosis of CP was based on endoscopic ultrasonography or magnetic resonance imaging. PEI was investigated by the (13)C-mixed triglyceride breath test. Hemoglobin, mean corpuscular volume, lymphocytes, prothrombin time, and serum levels of total protein, albumin, prealbumin, retinol binding protein, cholesterol, triglycerides, amylase, folic acid, vitamin B12, HbA1C, transferrin, ferritin, magnesium and zinc were analyzed.

Results: 114 patients were included in the study (97 males, mean age 48.1 years, 54 with alcohol etiology), 38 (33%) suffered from PEI. Magnesium below 2.05 mg/dL, hemoglobin, albumin, prealbumin and retinol binding protein below lower limit of normal and HbA1C above upper limit of normal were associated with PEI in univariate analysis. Magnesium below 2.05 mg/dL detected PEI with a sensitivity, specificity and positive and negative predictive values of 0.88 (95% confidence interval, 0.66-0.97), 0.66 (0.48-0.80), 0.58 (0.39-0.75) and 0.91 (0.73-0.98), respectively. The corresponding values were 1.00 (0.80-1.00), 0.55 (0.38-0.71), 0.52 (0.34-0.69) and 1.00 (0.82-1.00)) if one or more pathological tests among parameters significantly associated with PEI in was used as a positive test for PEI.

Conclusion: Serum nutritional markers can be used to predict the probability of PEI in CP and provide guidance in decisions on enzyme replacement therapy.

Citing Articles

European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations.

Dominguez-Munoz J, Vujasinovic M, de la Iglesia D, Cahen D, Capurso G, Gubergrits N United European Gastroenterol J. 2024; 13(1):125-172.

PMID: 39639485 PMC: 11866322. DOI: 10.1002/ueg2.12674.


Association between severity of pancreatic exocrine insufficiency and computed tomography-based morphological severity in patients with chronic pancreatitis.

Lee J, Lee S, Choi Y, Han S, Jo J, Choe J Medicine (Baltimore). 2024; 103(48):e40737.

PMID: 39612393 PMC: 11608721. DOI: 10.1097/MD.0000000000040737.


Clinical Efficacy and Safety of Treatments for Exocrine Pancreatic Insufficiency: A Systematic Literature Review.

Chu P, Mioc J, ODonovan P, Henry O Digestion. 2024; 106(1):45-61.

PMID: 39299226 PMC: 11825132. DOI: 10.1159/000541326.


Dysregulated serum concentrations of fat-soluble vitamins in dogs with chronic enteropathy.

Serafini F, Maxwell K, Zhu X, Lennon E J Vet Intern Med. 2024; 38(5):2612-2619.

PMID: 39087781 PMC: 11423464. DOI: 10.1111/jvim.17107.


High hand grip strength is a significant risk factor and a useful predictor of postoperative pancreatic fistula following pancreaticoduodenectomy.

Nakajima T, Ikuta S, Fujikawa M, Ikuta L, Matsuki G, Ichise N Langenbecks Arch Surg. 2024; 409(1):85.

PMID: 38438660 DOI: 10.1007/s00423-024-03274-3.